Skip to main content
Premium Trial:

Request an Annual Quote

Helicos Again Cuts IPO Share Price, Down 40 Percent From High End of Original Price Range

NEW YORK (GenomeWeb News) — Helicos for the second time in a week ratcheted down its share price for its planned initial public offering, cutting the price of its shares to $9 — a 40-percent drop from the high end of its original plan — according to a filing with the US Securities and Exchange Commission today.
Earlier this week, the company cut the price of the 5.4 million shares it is offering to between $10 and $11 per share from an original projection of between $13 and $15 per share, according to an earlier SEC filing.
Helicos now expects to raise about $43.2 million in net proceeds from the IPO, and as much as $50 million if underwriters fully exercise an over-allotment option.
The firm's adjusted capitalization also was cut to $66.7 million to reflect the lower proceeds.
Helicos said it plans to use about $20 million of the proceeds to develop its HeliScope system and its tSMS technology.
The remaining $20 million or so will pay for sales, marketing, and manufacturing efforts for the HeliScope.
In a prospectus filed on May 7, Helicos initially estimated it would price its shares in the $13 to $15 range, but on May 23 the company reduced that range to between $10 and $11 per share.
As GenomeWeb Daily News reported at the time, if the Helicos IPO is successful the firm will become the only publicly traded pure-play next-generation sequencing company.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.